Home > Health

Gilead Sciences to Provide Free Truvada to Support U.S. Initiative to End the HIV Epidemic

– Donation Provides up to 2.4 Million Free Bottles Annually to Uninsured Americans at Risk for HIV FOSTER CITY, Calif: Gilead Sciences, Inc. (Nasdaq: GILD) Thursday announced that it will donate Truvada for PrEP® (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg tablets) to the U.S. Centers for Disease Control and Prevention (CDC)

Read More